Genome Investigation Pty Ltd

This Australian company commenced activity in 2013 with the aim of bringing MammaPrint and BluePrint technology to Australian women. Based in Port Macquarie in New South Wales, Genome Investigation Pty Ltd is committed to the rapid transportation of breast cancer tissue of affected women from Australian pathology laboratories to the Agendia Laboratory in California, USA, to ensure a quick turn around reporting time is made possible (usually under 2 weeks).